With ubituximab, a high percentage of patients maintained no signs of disease activity.

ISC: International Stroke Conference

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years Later

Impairment persisted after episodes of cerebral malaria or severe malarial anemia

Rat Lungworm Is Now in My State. Is It in Yours Too?

The global, brain-invading parasite continues to spread

Suppressing a Sneeze May Have Led to Cerebrospinal Fluid Leak

While normally harmless, holding in a sneeze may in rare cases cause serious problems

Novel Agent Reduces Seizures in Treatment-Resistant Epilepsy

Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study

Stiff Person Syndrome Patients Regain Mobility After Single-Dose Cell Therapy

CAR-T therapy shows promise in clinical trial

Cemdisiran siRNA Therapy Demonstrates Efficacy in Myasthenia Gravis

Investigational treatment improves outcomes without complete complement blockade

First Clinical Trial in MOGAD Meets Primary Endpoint

Satralizumab cuts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

No new signals for lecanemab emerged in ALZ-NET

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

Investigational deramiocel is back under FDA review again

CDC Study Reveals a Sleep-Deprived Nation

Women were more likely than men to have trouble falling and staying asleep

Decoding Coffee-Dementia Links; Three Alzheimer's Trajectories; Mumps Encephalitis

News and commentary from the world of neurology and neuroscience

First-Time Seizures Linked to Higher Cancer Risk, Study Finds

Seizures may be a clue to non-neurologic cancer, not just brain tumors

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Shift to uncertainty-based statements appears to increase vaccine hesitancy, according to study

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

South Korean study found no increased risk for 12 disorders among exposed offspring

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

Oral NMDA receptor antagonist gets an expanded indication